Logo
x

Search category

Subscribe Now

P-IIIb

Janssen Reports Post-Hoc Analysis of P-III GRIPHON and P-IIIb TRITON Studies of Uptravi (selexipag) for the Treatment of Pulmonary Arterial Hypertension #ESC2021

Janssen Reports Post-Hoc Analysis of P-III GRIPHON and P-IIIb TRITON Studies of Uptravi (selexipag) for the Treatment of Pulmonary...

  • August 31, 2021
Janssen's Stelara Fails to Show Superiority over AbbVie's Humira in P-IIIb SEAVUE Study for Crohn's Disease- Presented at DDW 2021

Janssen's Stelara Fails to Show Superiority over AbbVie's Humira in P-IIIb SEAVUE Study for Crohn's Disease- Presented at DDW 2021

  • May 25, 2021
Novartis Reports Results of Cosentyx (secukinumab) in P-IIIb ULTIMATE Study for Psoriatic Arthritis

Novartis Reports Results of Cosentyx (secukinumab) in P-IIIb ULTIMATE Study for Psoriatic Arthritis

  • November 5, 2020
Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma

Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma

  • June 5, 2020
Roche Reports Updated Results of Hemlibra (emicizumab) in P-III HAVEN and P-IIIb STASEY Studies for Hemophilia A

Roche Reports Updated Results of Hemlibra (emicizumab) in P-III HAVEN and P-IIIb STASEY Studies for Hemophilia A

  • July 9, 2019
Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults

Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults

  • July 2, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.